Pulmonary surfactant is a critical component of lung function in healthy individuals. It
functions in part by lowering surface tension in the alveoli, thereby allowing for breathing …

Because of the high demand of organs, the usage of marginal grafts has increased. These
marginal organs have a higher risk of developing ischemia-reperfusion injury, which can …

Acute respiratory distress syndrome (ARDS) is undefined in neonates, despite the long-
standing existing formal recognition of ARDS syndrome in later life. We describe the …

Pulmonary surfactant is a lipoprotein complex lining the alveolar surface to decrease the
surface tension and facilitate inspiration. Surfactant deficiency is often seen in premature …

Background COVID-19 causes acute respiratory distress syndrome (ARDS) and depletes
the lungs of surfactant, leading to prolonged mechanical ventilation and death. The …

Objectives The aim of this review is to summarize the current state-of-the-art in poly (lactic-co-
glycolic acid)(PLGA) carriers for inhalation. It presents the rational of use, the potential and …

Protective ventilation strategies for the injured lung currently revolve around the use of low
Vt, ostensibly to avoid volutrauma, together with positive end-expiratory pressure to increase …

Introduction The dramatic impact of COVID-19 on humans worldwide has initiated an
extraordinary search for effective treatment approaches. One of these is the administration of …

The pulmonary surfactant (PS) is a complex mixture of lipids and proteins dispersed in the
aqueous lining layer of the alveolar surface. Such a layer plays a key role in maintaining the …

The novel coronavirus disease (COVID-19) has many characteristics common to those in
two other coronavirus acute respiratory diseases, severe acute respiratory syndrome …